Luye Pharma Group recently released the encouraging top-line results from a Phase II clinical trial of its new antidepressant, Ansofaxine Hydrochloride Extended-Release Tablets (LY03005),
Korea's Samsung Biologics Looks Strategically At PharmAbcine Deal
PharmAbcine Inc. ntered into a strategic partnership with Samsung Biologics for the development and manufacturing of PMC-403 pipeline, the next generation therapeutic antibody candidate
Chinese Pharma Company Revamps For Longterm Covid-19 Support
Amidst the continued impact of COVID-19 on people around the globe, Infinitus (China) Company Ltd, a purveyor of health products and solutions, says it
Transcenta Holding Names New Global Clinical Development SVP
Transcenta Holding Limited, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the appointment of Dr.
China's Active Pharmaceutical Ingredients Sector Gets A Boost
PharmaSources.com, the vertical B2B portal for the pharmaceutical industry, announced the launch of the virtual session CPhI China Top API Exporters & Products on
Chinese Firm Buys American Pharmaceutical Ingredients Company
Shenzhen Hepalink Pharmaceutical Company Ltd. is paying at least USD337.5 million to acquire an American company.